Among this family, although IGF2BP3 is newly reported, it has been extensively studied to increase the mRNA stability and translation of oncogenes thus promoting tumorigenesis in several human cancers, such as pancreatic cancer [16], kidney cancer [17], gastric cancer [18], lung cancer [19], breast cancer [20], and hepatocellular carcinoma [21]. Here, IGF2BP3 is linked to cancer.